440 filings
Page 9 of 22
424B3
won4nwts 3bp8r
24 Apr 20
Prospectus supplement
4:05pm
DEFA14A
pshz2a
24 Apr 20
Additional proxy soliciting materials
6:09am
CORRESP
t70nowkqb9hcvx3gkp
22 Apr 20
Correspondence with SEC
12:00am
S-4/A
vycd37qil fsoro
21 Apr 20
Registration of securities issued in business combination transactions (amended)
5:09pm
UPLOAD
1yhfizsuzcn3y4
14 Apr 20
Letter from SEC
12:00am
8-K
ybvilid l0dp9m
8 Apr 20
Departure of Directors or Certain Officers
4:05pm
S-4
trpdw3c4txe27vw 6v7v
6 Apr 20
Registration of securities issued in business combination transactions
5:24pm
425
zw33gg
25 Mar 20
Business combination disclosure
4:01pm
425
q6jktj
17 Mar 20
Business combination disclosure
12:00am
425
pc3dtt20meubv8erlhr
16 Mar 20
Business combination disclosure
4:10pm
S-8
gz9nqmqra
16 Mar 20
Registration of securities for employees
4:08pm
8-K
2njlyhkao6uykw
16 Mar 20
AcelRx Pharmaceuticals to Acquire Tetraphase Pharmaceuticals
3:24pm
425
uw3fkpz9p5
16 Mar 20
Business combination disclosure
3:22pm
8-K
zf4s2xw5bvaj5e4
16 Mar 20
AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
7:40am
8-K
5kr95cjc6k5 n6tck
13 Jan 20
AcelRx Announces Year-End 2019 MetricsĀ and Provides Corporate Updates
7:06am
UPLOAD
ep1v8f63
25 Nov 19
Letter from SEC
12:00am
CORRESP
lf9q4ed90gnvp
7 Nov 19
Correspondence with SEC
12:00am